Skip to main content
Clinical Trials/DRKS00017543
DRKS00017543
Completed
未知

Comparing the effectiveness of the treatment of hidradenitis suppurativa (acne inversa) with the combination of LAight® therapy with guideline-based drug therapy in relation to guideline-based drug therapy alone - RELIEVE

Overview

Phase
未知
Intervention
Not specified
Conditions
L73.2
Sponsor
niversitätsmedizin der Johannes Gutenberg-Universität Mainz
Enrollment
88
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 25, 2019
End Date
March 10, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \= 18;
  • 2\. Disease severity: Hurley stage 1 or Hurley stage 2;
  • 3\. At least one affected area typical for HS (axillary, inguinal, gluteal, mammary);
  • 4\. At least 3 inflammatory nodules or abscesses;
  • 5\. The mental ability to understand the patient information and follow the study procedure.

Exclusion Criteria

  • 1\. Disease severity: Hurley stage 3;
  • 2\. Medical guideline therapy not possible;
  • 3\. Other disease that leads to systemic Inflammation;
  • 4\. Therapy with antibiotics or retinoids within the last 2 weeks;
  • 5\. Pre\-treatment with the LAight®\-therapy;
  • 6\. Contraindications LAight®\-therapy;
  • a) Pregnancy;
  • b) Epilepsy;
  • c) Electronically controlled implants (e.g. Pacemaker, cardiac stimulator)
  • d) Extreme photosensitivity (also of a medicinal nature);

Outcomes

Primary Outcomes

Not specified

Similar Trials